Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects.
Phase of Trial: Phase II
Latest Information Update: 19 Aug 2009
At a glance
- Drugs Tolterodine (Primary)
- Indications Overactive bladder
- Focus Pharmacodynamics
- 19 Aug 2009 Planned number of patients changed from 36 to 36.
- 19 Aug 2009 New trial record